Synlogic, Inc., (Nasdaq: SYBX) announced on 8/13/18 the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, in... read more
Synlogic, Inc., (Nasdaq: SYBX) announced on 8/13/18 the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, in... read more
UF Innovate | Sid Martin Biotech, a biotechnology incubator at the University of Florida, announced on 8/13/18 that resident company Lacerta... read more
... read more
Azitra Awarded NIH SBIR Grant to Develop Microbiome – based Therapeutic for Netherton Syndrome
... read more
Neuralstem, Inc. (Nasdaq:CUR) announced on 8/9/18 that the U.S. Food and Drug Administration has granted orphan drug designation to NSI-189 for the... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,